image stringlengths 20 66 | question stringclasses 16
values | answer stringlengths 3 10.7k |
|---|---|---|
PMC9412607_vetsci-09-00444-f002_384869.jpg | What is the central feature of this picture? | Representative photomicrographs for the histopathologic identification of hyphae morphologically consistent with Pythium sp. (arrows). (A). H&E stain; (B). GMS stain; and (C). PAS stain. |
PMC9412607_vetsci-09-00444-f002_384870.jpg | What object or scene is depicted here? | Representative photomicrographs for the histopathologic identification of hyphae morphologically consistent with Pythium sp. (arrows). (A). H&E stain; (B). GMS stain; and (C). PAS stain. |
PMC9412618_medicina-58-01060-f001_384871.jpg | Can you identify the primary element in this image? | Images of contrast-enhanced abdominal computed tomography on (A) first and (B) 15th day of hospitalization. These images show wedge-shaped lesions with decreased contrast enhancement in right kidney (white arrows). |
PMC9412618_medicina-58-01060-f001_384872.jpg | What stands out most in this visual? | Images of contrast-enhanced abdominal computed tomography on (A) first and (B) 15th day of hospitalization. These images show wedge-shaped lesions with decreased contrast enhancement in right kidney (white arrows). |
PMC9412654_polymers-14-03373-f009_384879.jpg | What is the focal point of this photograph? | Detection results of cracks in FRP bonded with 1 mm thick SIR. (a) The 628th frame 1st DTI. (b) The 819th frame 1st DTI. (c) The 589th frame 2nd DTI. (d) The 829th frame 2nd DTI. (e) FDTI from subtracting 1st DTIs. (f) FDTI from subtracting 2nd DTIs. |
PMC9412654_polymers-14-03373-f009_384875.jpg | What object or scene is depicted here? | Detection results of cracks in FRP bonded with 1 mm thick SIR. (a) The 628th frame 1st DTI. (b) The 819th frame 1st DTI. (c) The 589th frame 2nd DTI. (d) The 829th frame 2nd DTI. (e) FDTI from subtracting 1st DTIs. (f) FDTI from subtracting 2nd DTIs. |
PMC9412654_polymers-14-03373-f009_384878.jpg | What object or scene is depicted here? | Detection results of cracks in FRP bonded with 1 mm thick SIR. (a) The 628th frame 1st DTI. (b) The 819th frame 1st DTI. (c) The 589th frame 2nd DTI. (d) The 829th frame 2nd DTI. (e) FDTI from subtracting 1st DTIs. (f) FDTI from subtracting 2nd DTIs. |
PMC9412654_polymers-14-03373-f009_384874.jpg | What key item or scene is captured in this photo? | Detection results of cracks in FRP bonded with 1 mm thick SIR. (a) The 628th frame 1st DTI. (b) The 819th frame 1st DTI. (c) The 589th frame 2nd DTI. (d) The 829th frame 2nd DTI. (e) FDTI from subtracting 1st DTIs. (f) FDTI from subtracting 2nd DTIs. |
PMC9412654_polymers-14-03373-f009_384876.jpg | What is the main focus of this visual representation? | Detection results of cracks in FRP bonded with 1 mm thick SIR. (a) The 628th frame 1st DTI. (b) The 819th frame 1st DTI. (c) The 589th frame 2nd DTI. (d) The 829th frame 2nd DTI. (e) FDTI from subtracting 1st DTIs. (f) FDTI from subtracting 2nd DTIs. |
PMC9412676_materials-15-05505-f005_384880.jpg | Describe the main subject of this image. | (a) Optical photograph of separator for K metal anode after cycles at 0.5 A g−1 with rGO@GF separator; top (b) and side (c,d) view of SEM and mapping (e,f) images of cycled rGO@GF separator. |
PMC9412676_materials-15-05505-f005_384884.jpg | What's the most prominent thing you notice in this picture? | (a) Optical photograph of separator for K metal anode after cycles at 0.5 A g−1 with rGO@GF separator; top (b) and side (c,d) view of SEM and mapping (e,f) images of cycled rGO@GF separator. |
PMC9412676_materials-15-05505-f005_384883.jpg | What can you see in this picture? | (a) Optical photograph of separator for K metal anode after cycles at 0.5 A g−1 with rGO@GF separator; top (b) and side (c,d) view of SEM and mapping (e,f) images of cycled rGO@GF separator. |
PMC9412676_materials-15-05505-f005_384881.jpg | What is the central feature of this picture? | (a) Optical photograph of separator for K metal anode after cycles at 0.5 A g−1 with rGO@GF separator; top (b) and side (c,d) view of SEM and mapping (e,f) images of cycled rGO@GF separator. |
PMC9412676_materials-15-05505-f005_384882.jpg | What is the main focus of this visual representation? | (a) Optical photograph of separator for K metal anode after cycles at 0.5 A g−1 with rGO@GF separator; top (b) and side (c,d) view of SEM and mapping (e,f) images of cycled rGO@GF separator. |
PMC9412683_polymers-14-03262-f004_384887.jpg | What can you see in this picture? | Microscopic cross-sections of core/sheath PL-POFs (DR = 1.1 and DR = 1.6) with doped COP core and pure THVP sheath. |
PMC9412689_pharmaceutics-14-01651-f009_384888.jpg | What is the main focus of this visual representation? | Representative SPECT/CT images of the 99mTcO4− biodistribution in healthy rats at 1 and 3 h after injection. The accumulation mainly occurs in the stomach. Images are from the same rat. |
PMC9412689_pharmaceutics-14-01651-f009_384889.jpg | What is the principal component of this image? | Representative SPECT/CT images of the 99mTcO4− biodistribution in healthy rats at 1 and 3 h after injection. The accumulation mainly occurs in the stomach. Images are from the same rat. |
PMC9412689_pharmaceutics-14-01651-f010_384890.jpg | Describe the main subject of this image. | Representative SPECT/CT images of the lipomics’ biodistribution at 1, 3, and 6 h after injection in healthy rats. The accumulation mainly occurs in the liver. Images are from the same rat. |
PMC9412689_pharmaceutics-14-01651-f010_384892.jpg | Describe the main subject of this image. | Representative SPECT/CT images of the lipomics’ biodistribution at 1, 3, and 6 h after injection in healthy rats. The accumulation mainly occurs in the liver. Images are from the same rat. |
PMC9412689_pharmaceutics-14-01651-f010_384891.jpg | What object or scene is depicted here? | Representative SPECT/CT images of the lipomics’ biodistribution at 1, 3, and 6 h after injection in healthy rats. The accumulation mainly occurs in the liver. Images are from the same rat. |
PMC9412690_tropicalmed-07-00185-f001_384896.jpg | What does this image primarily show? | Main MR findings of patients. Axial contrast-enhanced image shows meningeal increased signal intensity accordingly to the clinical suspect of meningitis in patients 3, 4, 6 and 9 (respectively, P3, P4, P6 and P9). |
PMC9412690_tropicalmed-07-00185-f001_384898.jpg | What is the central feature of this picture? | Main MR findings of patients. Axial contrast-enhanced image shows meningeal increased signal intensity accordingly to the clinical suspect of meningitis in patients 3, 4, 6 and 9 (respectively, P3, P4, P6 and P9). |
PMC9412690_tropicalmed-07-00185-f001_384900.jpg | What is the main focus of this visual representation? | Main MR findings of patients. Axial contrast-enhanced image shows meningeal increased signal intensity accordingly to the clinical suspect of meningitis in patients 3, 4, 6 and 9 (respectively, P3, P4, P6 and P9). |
PMC9412690_tropicalmed-07-00185-f001_384894.jpg | What is the focal point of this photograph? | Main MR findings of patients. Axial contrast-enhanced image shows meningeal increased signal intensity accordingly to the clinical suspect of meningitis in patients 3, 4, 6 and 9 (respectively, P3, P4, P6 and P9). |
PMC9412690_tropicalmed-07-00185-f001_384897.jpg | What key item or scene is captured in this photo? | Main MR findings of patients. Axial contrast-enhanced image shows meningeal increased signal intensity accordingly to the clinical suspect of meningitis in patients 3, 4, 6 and 9 (respectively, P3, P4, P6 and P9). |
PMC9412690_tropicalmed-07-00185-f001_384893.jpg | What's the most prominent thing you notice in this picture? | Main MR findings of patients. Axial contrast-enhanced image shows meningeal increased signal intensity accordingly to the clinical suspect of meningitis in patients 3, 4, 6 and 9 (respectively, P3, P4, P6 and P9). |
PMC9412690_tropicalmed-07-00185-f001_384899.jpg | What stands out most in this visual? | Main MR findings of patients. Axial contrast-enhanced image shows meningeal increased signal intensity accordingly to the clinical suspect of meningitis in patients 3, 4, 6 and 9 (respectively, P3, P4, P6 and P9). |
PMC9412695_micromachines-13-01267-f007_384903.jpg | What is the core subject represented in this visual? | Simulated 3D and 2D patterns when (a) Ant. 8 excited at 3.5 GHz and (b) Ant. 7 excited at 4.9 GHz. |
PMC9412695_micromachines-13-01267-f007_384904.jpg | What key item or scene is captured in this photo? | Simulated 3D and 2D patterns when (a) Ant. 8 excited at 3.5 GHz and (b) Ant. 7 excited at 4.9 GHz. |
PMC9412702_pharmaceutics-14-01679-f003_384906.jpg | What object or scene is depicted here? | Cone beam computed tomography (CBCT) images detect the presence of apical inflammatory lesions. This type of empirical evidence for oral infections is used as a method of deciding treatment course by dentists. (A) CBCT sagittal image shows an apical inflammatory lesion as a darker grey pocket surrounding the apex of to... |
PMC9412702_pharmaceutics-14-01679-f003_384905.jpg | What is the main focus of this visual representation? | Cone beam computed tomography (CBCT) images detect the presence of apical inflammatory lesions. This type of empirical evidence for oral infections is used as a method of deciding treatment course by dentists. (A) CBCT sagittal image shows an apical inflammatory lesion as a darker grey pocket surrounding the apex of to... |
PMC9412773_materials-15-05522-f019_384910.jpg | Describe the main subject of this image. | The clod cracks in HAZ of the CM-247LC substrate (the laser power is 1000 w, and the scanning speed is 199 mm/min) [103]. |
PMC9412773_materials-15-05522-f019_384909.jpg | What is the dominant medical problem in this image? | The clod cracks in HAZ of the CM-247LC substrate (the laser power is 1000 w, and the scanning speed is 199 mm/min) [103]. |
PMC9412773_materials-15-05522-f028_384915.jpg | Describe the main subject of this image. | Microstructure of Fe-based alloy laser cladding coating (the laser power is 1.9 kw, and the scanning speed is 200 mm/min): (a) without La2O3; (b) with 0.4% La2O3; (c) with 1.2% La2O3; (d) with 2.0% La2O3 [58]. |
PMC9412773_materials-15-05522-f028_384914.jpg | What can you see in this picture? | Microstructure of Fe-based alloy laser cladding coating (the laser power is 1.9 kw, and the scanning speed is 200 mm/min): (a) without La2O3; (b) with 0.4% La2O3; (c) with 1.2% La2O3; (d) with 2.0% La2O3 [58]. |
PMC9412773_materials-15-05522-f028_384912.jpg | What stands out most in this visual? | Microstructure of Fe-based alloy laser cladding coating (the laser power is 1.9 kw, and the scanning speed is 200 mm/min): (a) without La2O3; (b) with 0.4% La2O3; (c) with 1.2% La2O3; (d) with 2.0% La2O3 [58]. |
PMC9412773_materials-15-05522-f028_384913.jpg | Can you identify the primary element in this image? | Microstructure of Fe-based alloy laser cladding coating (the laser power is 1.9 kw, and the scanning speed is 200 mm/min): (a) without La2O3; (b) with 0.4% La2O3; (c) with 1.2% La2O3; (d) with 2.0% La2O3 [58]. |
PMC9412840_microorganisms-10-01635-f002_384916.jpg | Can you identify the primary element in this image? | Microscopic observation (×40) of the hyphal structure of P. schmitthenneri co-cultured with the antagonistic bacteria after 6 days of incubation. (A) untreated control; (B) vacuolation (SF14); (C) deformation (ACBC2); (D) hyphal swelling (ACBC1); (E) degradation of the mycelium (BM3-5); (F) budding of the mycelium stru... |
PMC9412840_microorganisms-10-01635-f002_384917.jpg | What is shown in this image? | Microscopic observation (×40) of the hyphal structure of P. schmitthenneri co-cultured with the antagonistic bacteria after 6 days of incubation. (A) untreated control; (B) vacuolation (SF14); (C) deformation (ACBC2); (D) hyphal swelling (ACBC1); (E) degradation of the mycelium (BM3-5); (F) budding of the mycelium stru... |
PMC9412840_microorganisms-10-01635-f002_384919.jpg | What does this image primarily show? | Microscopic observation (×40) of the hyphal structure of P. schmitthenneri co-cultured with the antagonistic bacteria after 6 days of incubation. (A) untreated control; (B) vacuolation (SF14); (C) deformation (ACBC2); (D) hyphal swelling (ACBC1); (E) degradation of the mycelium (BM3-5); (F) budding of the mycelium stru... |
PMC9412840_microorganisms-10-01635-f002_384918.jpg | What does this image primarily show? | Microscopic observation (×40) of the hyphal structure of P. schmitthenneri co-cultured with the antagonistic bacteria after 6 days of incubation. (A) untreated control; (B) vacuolation (SF14); (C) deformation (ACBC2); (D) hyphal swelling (ACBC1); (E) degradation of the mycelium (BM3-5); (F) budding of the mycelium stru... |
PMC9412840_microorganisms-10-01635-f002_384920.jpg | What is the central feature of this picture? | Microscopic observation (×40) of the hyphal structure of P. schmitthenneri co-cultured with the antagonistic bacteria after 6 days of incubation. (A) untreated control; (B) vacuolation (SF14); (C) deformation (ACBC2); (D) hyphal swelling (ACBC1); (E) degradation of the mycelium (BM3-5); (F) budding of the mycelium stru... |
PMC9412870_nanomaterials-12-02767-f008_384923.jpg | What is being portrayed in this visual content? | SEM micrographs of MgVO/C at different magnifications. |
PMC9412870_nanomaterials-12-02767-f008_384922.jpg | What stands out most in this visual? | SEM micrographs of MgVO/C at different magnifications. |
PMC9412875_pharmaceuticals-15-00996-f003_384926.jpg | What key item or scene is captured in this photo? | Representative maximal intensity projections of 64Cu-DOTHA2-PSMA PET in LNCaP tumor-bearing mice without (a,c,e) and with (b,d,f) the co-injection of natCu-DOTHA2-PSMA as a blocking agent. (a,b) Average frames from 40 to 60 min p.i. from dynamic scans; (c,d) 4 h p.i. 20 min static scan; (e,f) 24 h p.i 1 h static scan. ... |
PMC9412875_pharmaceuticals-15-00996-f003_384925.jpg | What stands out most in this visual? | Representative maximal intensity projections of 64Cu-DOTHA2-PSMA PET in LNCaP tumor-bearing mice without (a,c,e) and with (b,d,f) the co-injection of natCu-DOTHA2-PSMA as a blocking agent. (a,b) Average frames from 40 to 60 min p.i. from dynamic scans; (c,d) 4 h p.i. 20 min static scan; (e,f) 24 h p.i 1 h static scan. ... |
PMC9412875_pharmaceuticals-15-00996-f003_384924.jpg | What is the core subject represented in this visual? | Representative maximal intensity projections of 64Cu-DOTHA2-PSMA PET in LNCaP tumor-bearing mice without (a,c,e) and with (b,d,f) the co-injection of natCu-DOTHA2-PSMA as a blocking agent. (a,b) Average frames from 40 to 60 min p.i. from dynamic scans; (c,d) 4 h p.i. 20 min static scan; (e,f) 24 h p.i 1 h static scan. ... |
PMC9412877_nutrients-14-03378-f001_384929.jpg | What is the focal point of this photograph? | Anticancer activity of selective AA restriction. Representative photographs at 20× magnification are shown. The detailed composition of M0 (a) and M1 (b) are shown in Table 1. |
PMC9412877_nutrients-14-03378-f001_384933.jpg | What is the central feature of this picture? | Anticancer activity of selective AA restriction. Representative photographs at 20× magnification are shown. The detailed composition of M0 (a) and M1 (b) are shown in Table 1. |
PMC9412877_nutrients-14-03378-f001_384937.jpg | What stands out most in this visual? | Anticancer activity of selective AA restriction. Representative photographs at 20× magnification are shown. The detailed composition of M0 (a) and M1 (b) are shown in Table 1. |
PMC9412877_nutrients-14-03378-f001_384940.jpg | What is being portrayed in this visual content? | Anticancer activity of selective AA restriction. Representative photographs at 20× magnification are shown. The detailed composition of M0 (a) and M1 (b) are shown in Table 1. |
PMC9412877_nutrients-14-03378-f001_384930.jpg | What is the main focus of this visual representation? | Anticancer activity of selective AA restriction. Representative photographs at 20× magnification are shown. The detailed composition of M0 (a) and M1 (b) are shown in Table 1. |
PMC9412877_nutrients-14-03378-f001_384934.jpg | What is being portrayed in this visual content? | Anticancer activity of selective AA restriction. Representative photographs at 20× magnification are shown. The detailed composition of M0 (a) and M1 (b) are shown in Table 1. |
PMC9412877_nutrients-14-03378-f001_384935.jpg | What is the central feature of this picture? | Anticancer activity of selective AA restriction. Representative photographs at 20× magnification are shown. The detailed composition of M0 (a) and M1 (b) are shown in Table 1. |
PMC9412877_nutrients-14-03378-f001_384927.jpg | What is the dominant medical problem in this image? | Anticancer activity of selective AA restriction. Representative photographs at 20× magnification are shown. The detailed composition of M0 (a) and M1 (b) are shown in Table 1. |
PMC9412877_nutrients-14-03378-f001_384941.jpg | What is shown in this image? | Anticancer activity of selective AA restriction. Representative photographs at 20× magnification are shown. The detailed composition of M0 (a) and M1 (b) are shown in Table 1. |
PMC9412877_nutrients-14-03378-f001_384939.jpg | What stands out most in this visual? | Anticancer activity of selective AA restriction. Representative photographs at 20× magnification are shown. The detailed composition of M0 (a) and M1 (b) are shown in Table 1. |
PMC9412877_nutrients-14-03378-f001_384931.jpg | What key item or scene is captured in this photo? | Anticancer activity of selective AA restriction. Representative photographs at 20× magnification are shown. The detailed composition of M0 (a) and M1 (b) are shown in Table 1. |
PMC9412877_nutrients-14-03378-f001_384928.jpg | What is being portrayed in this visual content? | Anticancer activity of selective AA restriction. Representative photographs at 20× magnification are shown. The detailed composition of M0 (a) and M1 (b) are shown in Table 1. |
PMC9412879_pharmaceutics-14-01661-f003_384942.jpg | What is the dominant medical problem in this image? | SEM images of unloaded BNC. (a) 5000 magnifications; (b) 20,000 magnifications, n = 1. |
PMC9412894_polymers-14-03264-f004_384944.jpg | What is being portrayed in this visual content? | Optical images of green samples top surfaces printed according to the eight configurations in Table 3: (a) Nr. 5; (b) Nr. 4; (c) Nr. 1; (d) Nr. 2; (e) Nr. 7; (f) Nr. 8; (g) Nr. 6; (h) Nr. 3. |
PMC9412894_polymers-14-03264-f004_384947.jpg | What object or scene is depicted here? | Optical images of green samples top surfaces printed according to the eight configurations in Table 3: (a) Nr. 5; (b) Nr. 4; (c) Nr. 1; (d) Nr. 2; (e) Nr. 7; (f) Nr. 8; (g) Nr. 6; (h) Nr. 3. |
PMC9412894_polymers-14-03264-f004_384946.jpg | What is the dominant medical problem in this image? | Optical images of green samples top surfaces printed according to the eight configurations in Table 3: (a) Nr. 5; (b) Nr. 4; (c) Nr. 1; (d) Nr. 2; (e) Nr. 7; (f) Nr. 8; (g) Nr. 6; (h) Nr. 3. |
PMC9412894_polymers-14-03264-f004_384945.jpg | What is the central feature of this picture? | Optical images of green samples top surfaces printed according to the eight configurations in Table 3: (a) Nr. 5; (b) Nr. 4; (c) Nr. 1; (d) Nr. 2; (e) Nr. 7; (f) Nr. 8; (g) Nr. 6; (h) Nr. 3. |
PMC9412894_polymers-14-03264-f004_384951.jpg | What is the focal point of this photograph? | Optical images of green samples top surfaces printed according to the eight configurations in Table 3: (a) Nr. 5; (b) Nr. 4; (c) Nr. 1; (d) Nr. 2; (e) Nr. 7; (f) Nr. 8; (g) Nr. 6; (h) Nr. 3. |
PMC9412894_polymers-14-03264-f004_384950.jpg | What can you see in this picture? | Optical images of green samples top surfaces printed according to the eight configurations in Table 3: (a) Nr. 5; (b) Nr. 4; (c) Nr. 1; (d) Nr. 2; (e) Nr. 7; (f) Nr. 8; (g) Nr. 6; (h) Nr. 3. |
PMC9412917_F1_384958.jpg | Can you identify the primary element in this image? | TGFβ1 is strongly upregulated in benign prostatic hyperplasia (BPH) compared with normal prostate (NP). (A) Expression levels of TGFβ1 mRNA between BPH and NP in the GSE132714 data set. **p < 0.01. (B) Expression levels of TGFβ1 protein in BPH and NP tissues. Protein expression of TGFβ1 was assayed by immunohistochemic... |
PMC9412917_F1_384957.jpg | Can you identify the primary element in this image? | TGFβ1 is strongly upregulated in benign prostatic hyperplasia (BPH) compared with normal prostate (NP). (A) Expression levels of TGFβ1 mRNA between BPH and NP in the GSE132714 data set. **p < 0.01. (B) Expression levels of TGFβ1 protein in BPH and NP tissues. Protein expression of TGFβ1 was assayed by immunohistochemic... |
PMC9412917_F1_384952.jpg | What is the dominant medical problem in this image? | TGFβ1 is strongly upregulated in benign prostatic hyperplasia (BPH) compared with normal prostate (NP). (A) Expression levels of TGFβ1 mRNA between BPH and NP in the GSE132714 data set. **p < 0.01. (B) Expression levels of TGFβ1 protein in BPH and NP tissues. Protein expression of TGFβ1 was assayed by immunohistochemic... |
PMC9412917_F1_384955.jpg | What is the core subject represented in this visual? | TGFβ1 is strongly upregulated in benign prostatic hyperplasia (BPH) compared with normal prostate (NP). (A) Expression levels of TGFβ1 mRNA between BPH and NP in the GSE132714 data set. **p < 0.01. (B) Expression levels of TGFβ1 protein in BPH and NP tissues. Protein expression of TGFβ1 was assayed by immunohistochemic... |
PMC9412917_F1_384956.jpg | What is the central feature of this picture? | TGFβ1 is strongly upregulated in benign prostatic hyperplasia (BPH) compared with normal prostate (NP). (A) Expression levels of TGFβ1 mRNA between BPH and NP in the GSE132714 data set. **p < 0.01. (B) Expression levels of TGFβ1 protein in BPH and NP tissues. Protein expression of TGFβ1 was assayed by immunohistochemic... |
PMC9412956_fig1_384966.jpg | What object or scene is depicted here? | CLC droplets show differences
in texture when exposed to different
amphiphiles, while NLC droplets exposed to the same or similar materials
look structurally similar. (a) Droplets of a red-reflecting CLC mixture
prepared in buffer solutions containing different amphiphiles showed
remarkably different apparent textures.... |
PMC9412956_fig1_384960.jpg | What is the central feature of this picture? | CLC droplets show differences
in texture when exposed to different
amphiphiles, while NLC droplets exposed to the same or similar materials
look structurally similar. (a) Droplets of a red-reflecting CLC mixture
prepared in buffer solutions containing different amphiphiles showed
remarkably different apparent textures.... |
PMC9412956_fig1_384961.jpg | What is the central feature of this picture? | CLC droplets show differences
in texture when exposed to different
amphiphiles, while NLC droplets exposed to the same or similar materials
look structurally similar. (a) Droplets of a red-reflecting CLC mixture
prepared in buffer solutions containing different amphiphiles showed
remarkably different apparent textures.... |
PMC9412956_fig1_384967.jpg | What is the dominant medical problem in this image? | CLC droplets show differences
in texture when exposed to different
amphiphiles, while NLC droplets exposed to the same or similar materials
look structurally similar. (a) Droplets of a red-reflecting CLC mixture
prepared in buffer solutions containing different amphiphiles showed
remarkably different apparent textures.... |
PMC9412956_fig1_384962.jpg | What can you see in this picture? | CLC droplets show differences
in texture when exposed to different
amphiphiles, while NLC droplets exposed to the same or similar materials
look structurally similar. (a) Droplets of a red-reflecting CLC mixture
prepared in buffer solutions containing different amphiphiles showed
remarkably different apparent textures.... |
PMC9412956_fig1_384968.jpg | Can you identify the primary element in this image? | CLC droplets show differences
in texture when exposed to different
amphiphiles, while NLC droplets exposed to the same or similar materials
look structurally similar. (a) Droplets of a red-reflecting CLC mixture
prepared in buffer solutions containing different amphiphiles showed
remarkably different apparent textures.... |
PMC9412967_nanomaterials-12-02886-f002_384975.jpg | What is the dominant medical problem in this image? | Morphological micrographs of the composites at various magnifications: (a,b) MXene, (c,d) NiFe–LDH@MXene, and (e,f) NiFeCo–LDH@MXene composites. |
PMC9412967_nanomaterials-12-02886-f002_384972.jpg | What is the core subject represented in this visual? | Morphological micrographs of the composites at various magnifications: (a,b) MXene, (c,d) NiFe–LDH@MXene, and (e,f) NiFeCo–LDH@MXene composites. |
PMC9412967_nanomaterials-12-02886-f002_384970.jpg | Can you identify the primary element in this image? | Morphological micrographs of the composites at various magnifications: (a,b) MXene, (c,d) NiFe–LDH@MXene, and (e,f) NiFeCo–LDH@MXene composites. |
PMC9412974_F2_384976.jpg | What's the most prominent thing you notice in this picture? | A brief introduction to the atlas. A random figure of the P10 atlas (Supplementary material 4) shows the anteroposterior (AP) of –3.18 mm section. The midline of the brain is defined as mediolateral (ML) of 0.00 mm, and the dorsal surface is defined as dorsoventral (DV) of 0.00 mm. The upper right inset illustrates the... |
PMC9412989_pathogens-11-00840-f003_384986.jpg | What does this image primarily show? | Lasiodiplodia fici (ZHKU 21-0092; Holotype). (a) Upper view of an infected leaf. (b) Reverse view of an infected leave. (c) Upper and reverse view of colonies on PDA after seven days. (d) A pycnidium on PDA after 28 days. (e) Vertical section through a pycnidium. (f) Pycnidial wall. (g–i) Conidiogenous cells with devel... |
PMC9412989_pathogens-11-00840-f003_384983.jpg | What is the central feature of this picture? | Lasiodiplodia fici (ZHKU 21-0092; Holotype). (a) Upper view of an infected leaf. (b) Reverse view of an infected leave. (c) Upper and reverse view of colonies on PDA after seven days. (d) A pycnidium on PDA after 28 days. (e) Vertical section through a pycnidium. (f) Pycnidial wall. (g–i) Conidiogenous cells with devel... |
PMC9412989_pathogens-11-00840-f003_384988.jpg | What does this image primarily show? | Lasiodiplodia fici (ZHKU 21-0092; Holotype). (a) Upper view of an infected leaf. (b) Reverse view of an infected leave. (c) Upper and reverse view of colonies on PDA after seven days. (d) A pycnidium on PDA after 28 days. (e) Vertical section through a pycnidium. (f) Pycnidial wall. (g–i) Conidiogenous cells with devel... |
PMC9412989_pathogens-11-00840-f003_384981.jpg | What can you see in this picture? | Lasiodiplodia fici (ZHKU 21-0092; Holotype). (a) Upper view of an infected leaf. (b) Reverse view of an infected leave. (c) Upper and reverse view of colonies on PDA after seven days. (d) A pycnidium on PDA after 28 days. (e) Vertical section through a pycnidium. (f) Pycnidial wall. (g–i) Conidiogenous cells with devel... |
PMC9412989_pathogens-11-00840-f003_384985.jpg | What's the most prominent thing you notice in this picture? | Lasiodiplodia fici (ZHKU 21-0092; Holotype). (a) Upper view of an infected leaf. (b) Reverse view of an infected leave. (c) Upper and reverse view of colonies on PDA after seven days. (d) A pycnidium on PDA after 28 days. (e) Vertical section through a pycnidium. (f) Pycnidial wall. (g–i) Conidiogenous cells with devel... |
PMC9412989_pathogens-11-00840-f003_384984.jpg | What is shown in this image? | Lasiodiplodia fici (ZHKU 21-0092; Holotype). (a) Upper view of an infected leaf. (b) Reverse view of an infected leave. (c) Upper and reverse view of colonies on PDA after seven days. (d) A pycnidium on PDA after 28 days. (e) Vertical section through a pycnidium. (f) Pycnidial wall. (g–i) Conidiogenous cells with devel... |
PMC9412989_pathogens-11-00840-f003_384978.jpg | What is the main focus of this visual representation? | Lasiodiplodia fici (ZHKU 21-0092; Holotype). (a) Upper view of an infected leaf. (b) Reverse view of an infected leave. (c) Upper and reverse view of colonies on PDA after seven days. (d) A pycnidium on PDA after 28 days. (e) Vertical section through a pycnidium. (f) Pycnidial wall. (g–i) Conidiogenous cells with devel... |
PMC9412989_pathogens-11-00840-f003_384980.jpg | What is the dominant medical problem in this image? | Lasiodiplodia fici (ZHKU 21-0092; Holotype). (a) Upper view of an infected leaf. (b) Reverse view of an infected leave. (c) Upper and reverse view of colonies on PDA after seven days. (d) A pycnidium on PDA after 28 days. (e) Vertical section through a pycnidium. (f) Pycnidial wall. (g–i) Conidiogenous cells with devel... |
PMC9412994_pharmaceutics-14-01658-f003_384990.jpg | What is the principal component of this image? | PET images were obtained with [11C]domperidone and [11C]metoclopramide after selected doses of the P-gp inhibitor tariquidar (TQD). Representative PET images are summed from 0 to 30 min and were obtained at baseline and after P-gp inhibition (8 mg/kg TQD for [11C]metoclopramide and 15 mg/kg TQD for [11C]domperidone). |
PMC9413033_molecules-27-05053-f004_384994.jpg | Describe the main subject of this image. | SEM images of M-P-S materials synthesized from metal halides and (P + S) at 500 °C. The right images are higher magnification images of the products shown in the left images. |
PMC9413033_molecules-27-05053-f004_384998.jpg | What can you see in this picture? | SEM images of M-P-S materials synthesized from metal halides and (P + S) at 500 °C. The right images are higher magnification images of the products shown in the left images. |
PMC9413033_molecules-27-05053-f004_384995.jpg | What stands out most in this visual? | SEM images of M-P-S materials synthesized from metal halides and (P + S) at 500 °C. The right images are higher magnification images of the products shown in the left images. |
PMC9413033_molecules-27-05053-f004_384993.jpg | What is the focal point of this photograph? | SEM images of M-P-S materials synthesized from metal halides and (P + S) at 500 °C. The right images are higher magnification images of the products shown in the left images. |
PMC9413033_molecules-27-05053-f004_384992.jpg | What does this image primarily show? | SEM images of M-P-S materials synthesized from metal halides and (P + S) at 500 °C. The right images are higher magnification images of the products shown in the left images. |
PMC9413033_molecules-27-05053-f004_384999.jpg | What is the core subject represented in this visual? | SEM images of M-P-S materials synthesized from metal halides and (P + S) at 500 °C. The right images are higher magnification images of the products shown in the left images. |
PMC9413033_molecules-27-05053-f004_384996.jpg | What is shown in this image? | SEM images of M-P-S materials synthesized from metal halides and (P + S) at 500 °C. The right images are higher magnification images of the products shown in the left images. |
PMC9413033_molecules-27-05053-f005_385000.jpg | Describe the main subject of this image. | SEM images of M-P-S materials synthesized from metal halides and (P2S5 + P) at 500 °C. The right images are higher magnification images of the products shown in the left images. |
PMC9413033_molecules-27-05053-f005_385002.jpg | What is the core subject represented in this visual? | SEM images of M-P-S materials synthesized from metal halides and (P2S5 + P) at 500 °C. The right images are higher magnification images of the products shown in the left images. |
PMC9413033_molecules-27-05053-f005_385007.jpg | What does this image primarily show? | SEM images of M-P-S materials synthesized from metal halides and (P2S5 + P) at 500 °C. The right images are higher magnification images of the products shown in the left images. |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.